346 related articles for article (PubMed ID: 37304140)
41. The future of cancer therapy: exploring the potential of patient-derived organoids in drug development.
Avci CB; Bagca BG; Shademan B; Takanlou LS; Takanlou MS; Nourazarian A
Front Cell Dev Biol; 2024; 12():1401504. PubMed ID: 38835507
[TBL] [Abstract][Full Text] [Related]
42. Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy.
Wu W; Li X; Yu S
Acta Biomater; 2022 Jul; 146():23-36. PubMed ID: 35533925
[TBL] [Abstract][Full Text] [Related]
43. Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.
Wang HM; Zhang CY; Peng KC; Chen ZX; Su JW; Li YF; Li WF; Gao QY; Zhang SL; Chen YQ; Zhou Q; Xu C; Xu CR; Wang Z; Su J; Yan HH; Zhang XC; Chen HJ; Wu YL; Yang JJ
Cell Rep Med; 2023 Feb; 4(2):100911. PubMed ID: 36657446
[TBL] [Abstract][Full Text] [Related]
44. Organoids: The current status and biomedical applications.
Yang S; Hu H; Kung H; Zou R; Dai Y; Hu Y; Wang T; Lv T; Yu J; Li F
MedComm (2020); 2023 Jun; 4(3):e274. PubMed ID: 37215622
[TBL] [Abstract][Full Text] [Related]
45. Personalized Cancer Medicine: An Organoid Approach.
Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
[TBL] [Abstract][Full Text] [Related]
46. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
[TBL] [Abstract][Full Text] [Related]
47. Flourishing tumor organoids: History, emerging technology, and application.
Yang Q; Li M; Yang X; Xiao Z; Tong X; Tuerdi A; Li S; Lei L
Bioeng Transl Med; 2023 Sep; 8(5):e10559. PubMed ID: 37693042
[TBL] [Abstract][Full Text] [Related]
48. Tumor Organoid as a Drug Screening Platform for Cancer Research.
Mahbubi R; Yousefi N; Hamidieh AA; Gholizadeh F; Sisakht MM
Curr Stem Cell Res Ther; 2023 Oct; ():. PubMed ID: 37855289
[TBL] [Abstract][Full Text] [Related]
49. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
50. Patient-derived rectal cancer organoids-applications in basic and translational cancer research.
Yan Y; Cheong IH; Chen P; Li X; Wang X; Wang H
Front Oncol; 2022; 12():922430. PubMed ID: 35957894
[TBL] [Abstract][Full Text] [Related]
51. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
Ding L; Yang Y; Lu Q; Cao Z; Weygant N
Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
[TBL] [Abstract][Full Text] [Related]
52. Establishment and Maintenance of Human CRC-Derived Organoids for PcG Studies.
Della Chiara G; Pagani M
Methods Mol Biol; 2023; 2655():231-244. PubMed ID: 37213001
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
[TBL] [Abstract][Full Text] [Related]
54. Tumor Organoids as a Research Tool: How to Exploit Them.
Booij TH; Cattaneo CM; Hirt CK
Cells; 2022 Oct; 11(21):. PubMed ID: 36359838
[TBL] [Abstract][Full Text] [Related]
55. [Application and research progress of patient-derived organoids in the multimodality treatment of pancreatic cancer].
Wang HW; Ma XQ; Gao S; Hao JH
Zhonghua Wai Ke Za Zhi; 2024 May; 62(7):710-713. PubMed ID: 38808439
[TBL] [Abstract][Full Text] [Related]
56. Lung Cancer Organoids: The Rough Path to Personalized Medicine.
Rossi R; De Angelis ML; Xhelili E; Sette G; Eramo A; De Maria R; Cesta Incani U; Francescangeli F; Zeuner A
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954367
[TBL] [Abstract][Full Text] [Related]
57. Tumor organoids: From inception to future in cancer research.
Yang L; Yang S; Li X; Li B; Li Y; Zhang X; Ma Y; Peng X; Jin H; Fan Q; Wei S; Liu J; Li H
Cancer Lett; 2019 Jul; 454():120-133. PubMed ID: 30981763
[TBL] [Abstract][Full Text] [Related]
58. Organoids in lung cancer: A teenager with infinite growth potential.
Xu Y; Xin W; Yan C; Shi Y; Li Y; Hu Y; Ying K
Lung Cancer; 2022 Oct; 172():100-107. PubMed ID: 36041323
[TBL] [Abstract][Full Text] [Related]
59. Tumor organoid model of colorectal cancer (Review).
Yang C; Xiao W; Wang R; Hu Y; Yi K; Sun X; Wang G; Xu X
Oncol Lett; 2023 Aug; 26(2):328. PubMed ID: 37415635
[TBL] [Abstract][Full Text] [Related]
60. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
Xu H; Jiao D; Liu A; Wu K
J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
